India Genomics and Molecular Diagnostics Market Prospects to 2018
Driven by Automation and Introduction of New Technologies
Region:Asia
Product Code:KR198
May 2014
68
About the Report
The report titled 'India Genomics and Molecular Diagnostics Market Prospects to 2018 - Driven by Automation and Introduction of New Technologies' presents a comprehensive analysis of the industry aspects including market size by value of molecular diagnostics market in India. The report also entails the market share analysis and company profiles of major players operating in the molecular diagnostics market of India. The future analysis, trends and developments, government regulations and segmentation by application have also been discussed in the industry research report.
The advent of the latest inventions and technologies in accurate detection and quicker screening, and the prolific growth in genetic testing have driven the revenues of the Indian molecular diagnostics market in recent years. The increase in the number of patients stricken with infectious diseases have propelled the revenue growth in FY'2013, which has increased 14.3% to INR ~ million from INR ~ million in FY'2012.
Reagents led the revenues from the molecular diagnostics space with a percentage contribution of ~% of the total market in fiscal year 2013. The market has transformed from being a labor intensive to the inclusion of latest technologies. Majority of the reagents sales have historically been attributed to the diagnosis of infectious diseases such as tuberculosis, gonorrhea, Chlamydia and influenza virus, as well as the identification and predisposition to several conditions such as cancer and cystic fibrosis.
The molecular diagnostics reagents market in India is segmented on the basis of application which includes virology tests, cancer detection, tuberculosis testing, blood screening, HPV testing and others. Molecular diagnosis helps in providing critical information that the healthcare providers and patients need in order to make the right decisions. Molecular diagnostics help in detecting and measuring the presence of genetic material which are associated with a specific health condition.
The molecular diagnostics market in India is majorly dominated by the virology tests market with a share of ~% in FY'2013. The infectious diseases such as HIV, HPV, hepatitis B and C and tuberculosis are prevalent in India. The combination of infectious disease immunoassay and molecular testing offers a complete solution for diagnosis and monitoring of HIV and hepatitis. Tuberculosis is one of the major causes of deaths among the people of India. Tuberculosis testing market held a share of ~% in FY'2013 which has grown from 14.3% in FY'2008. It has been observed that in 2012 about 1.3 million people in the world were killed due to tuberculosis and India accounted for 26% of the total TB cases globally. The rising number of tuberculosis cases in the country has contributed to a strong growth of TB testing in the molecular diagnostics market of India.
With the health insurance cover expected to increase, the health insurance industry is expected to integrate strongly with diagnostic centres. As the number of people having health insurance policies increases and outpatient diagnostics gets covered, health insurance companies will partner with diagnostic centres for standardized services. Products with superior technologies such as broader range application equipment and multitasking reagents will continue to find a deeper penetration in the Indian molecular diagnostics market. New technologies also will bring greater effectiveness to current methods. Technologies such as nanotechnology are likely to support the development of the molecular diagnostics field. The molecular diagnostic market is presently at its growing stage in the country and is expected to capture a significant share in the in-vitro diagnostics market in the coming years.
KEY TOPICS COVERED IN THE REPORT
- The market size of India molecular diagnostics market in terms of value
- India molecular diagnostics market segmentation by reagents and instruments
- India molecular diagnostics instruments market segmentation by fully automated and semi-automated analyzers
- India molecular diagnostics reagents market segmentation by application (virology tests, tuberculosis testing, cancer detection, blood screening tests, HPV testing and others)
- India molecular diagnostics market segmentation by end users and manufacturers
- Market size of India virology tests using molecular diagnostics market
- Market size of India tuberculosis tests using molecular diagnostics market
- Market size of India cancer detection using molecular diagnostics market
- Market size of India molecular blood screening test market
- Market size of India molecular HPV tests market
- Market size of India other molecular tests market (genetic testing and industrial and food diagnostics)
- Trends and Developments and Government regulations in the molecular diagnostics market of India
- Market share of major players in India molecular diagnostics market
- Competitive landscape of India molecular diagnostics market
- Future projections and macro economic factors of India molecular diagnostics market
Products
Molecular Diagnostic, Reagents, Instruments, Semi-Automated Analyzers, Fully Automoted Analyzers, HPV Tests, Blood Screening Market, Cancer Detection,
Companies
Roche Diagnostics, Abbott Laboratories, Qiagen, BioMerieux, Lab India Healthcare
Table of Contents
1. India Genomics and Molecular Diagnostics Market Introduction
2. Government Regulations in Diagnostics Market in India
Government Incentives on Diagnostics
Manufacturing License
3. India Molecular Diagnostics Industry - Key Drivers
Rising Incidence of Chronic and Infectious Diseases
Rapidly Ageing Population
Rise in Point of Care Testing
Increased Physician Awareness to Better Clinical Outcomes
Improving Healthcare Infrastructure and Technology in India
Augmenting Purchasing Power and Mounting Health Consciousness
4. India Molecular Diagnostics Market Size, FY'2008-FY'2013
5. India Molecular Diagnostics Market Segmentation, FY'2008-FY'2013
5.1. By Reagents and Instruments, FY'2008-FY'2013
5.1.1. India Molecular Diagnostics Instruments Market Segmentation by Fully Automated and Semi-Automated Analyzers, FY'2008-FY'2013
5.1.2. India Molecular Diagnostics Reagents Market Segmentation by Application, FY'2008-FY'2013
5.1.2.1. India Virology Tests using Molecular Diagnostics Market Size, FY'2008-FY'2013
5.1.2.1.1. India Virology Tests Market Segmentation, FY'2013
5.1.2.2. India Tuberculosis Tests using Molecular Diagnostics Market Size, FY'2008-FY'2013
5.1.2.3. India Cancer Detection using Molecular Diagnostics Market Size, FY'2008-FY'2013
5.1.2.4. India Molecular Blood Screening Tests Market Size, FY'2008-FY'2013
5.1.2.5. India Molecular HPV Tests Market Size, FY'2008-FY'2013
5.1.2.6. India Other Molecular Tests Market Size, FY'2008-FY'2013
5.2. By End-Users, FY'2013
5.3. By Manufacturers
6. India Molecular Diagnostics Market Trends and Developments
Innovative Technology Transforming the Clinical Laboratory Medicine Industry
Companion Diagnostics
Mass Spectroscopy Offering One-Step Process
Microfluidic Approach for Point-of-Care (POC) Diagnostics
Rapid Development of Automated Systems
Development of Quicker and Sensitive High-Throughput Systems
7. Market Share of Major Players in India Molecular Diagnostics Market, FY'2013
8. Molecular Diagnostics Products of Major Players
9. Company Profiles of Major Players in India Molecular Diagnostics Market
10. India Genomics and Molecular Diagnostics Market Future Outlook and Projections, FY'2014-FY'2018
India Molecular Diagnostics Reagents Market Future Projections, FY'2014-FY'2018
10.1. Cause and Effect Relationship Analysis of the Molecular Diagnostics Market in India
11. Macro-Economic Factors
11.1. Population in India FY'2008-FY'2018
11.2. Personal Disposable Income in India, FY'2008-FY'2018
11.3. Consumer Expenditure on Healthcare in India, FY'2008-FY'2018
11.4. Government Expenditure on Healthcare in India, FY'2008-FY'2018
11.5. India Medical Devices Market Size, 2008-2018
11.6. FDI in Healthcare in India, FY'2008-FY'2013
12. Appendix
12.1. Market Definitions
12.2. Abbreviations
12.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Final Conclusion
12.4. Disclaimer
Why Buy From Us?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.